Caitlin Costello, MD
Caitlin Costello is an Associate Professor of Medicine at University of California, San Diego Health and board-certified hematologist and medical oncologist who specializes in treating a variety of blood cancers, including multiple myeloma, lymphoma, and leukemia. She is part of the joint UC San Diego Health / Sharp Blood and Marrow Transplantation (BMT) Program, which provides patients with the unique opportunity to receive care from the same physician throughout all phases of blood cancer treatment.
She received her medical degree at Tufts University School of Medicine in Boston. She completed her fellowship in hematology-oncology with a focus in bone marrow transplantation at UC San Diego School of Medicine and residency in internal medicine at Weill Cornell Medical College, New York–Presbyterian Hospital.
Her primary clinical interests include treating plasma cell disorders such as multiple myeloma, Waldenstrom’s macroglobulinemia and systemic amyloidosis. Her research focuses on refining the management and treatment of these diseases. She is committed to conducting clinical trials for multiple myeloma with novel agents and regimens, with a goal to broaden therapeutic options and knowledge of this disease.
Representative Publications:
Ibrutinib Alone or With Dexamethasone for Relapsed or Relapsed and Refractory Multiple Myeloma: Phase 2 Trial Results.
Multiple Myeloma, Version 2.2016: Clinical Practice Guidelines in Oncology.
Therapy sequencing strategies in multiple myeloma: who, what and why?
An Update on the Role of Daratumumab in the Treatment of Multiple Myeloma.
Alu-Dependent RNA Editing of GLI1 Promotes Malignant Regeneration in Multiple Myeloma.
